Similarly, JAK/STAT signaling pathway enriched by TFAP2A was reported to be activated in 50% of ICC, and might affect more than 70% of the ICC inflammation subclass [15]. This evidence concerns the gene SOAT1 and intrahepatic cholangiocarcinoma.